BioStock: PolarCool’s CEO sees increased demand for PolarCap

In an effort to bring its concussion treatment device to new markets around Europe, PolarCool has recently reached key agreements in Germany, the UK, and Finland. The company’s CEO Erik Andersson believes their business strategy will hasten their journey towards break-even. Read the full Q&A below.

Read the interview with Erik Andersson at biostock.se:

https://www.biostock.se/en/2022/09/polarcools-ceo-sees-increased-demand-for-polarcap/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/